Hanlon Suzanne M.
Insider CIK 1631682 · ZYNE Sec, VP & General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2021-01-21 | 2021-01-25 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2021-01-21 | 2021-01-25 | 37,000 | — | $0 | 80,693 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2020-01-30 | 2020-02-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2019-01-24 | 2019-01-28 | 52,859 | — | $0 | 52,859 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2018-08-06 | 2018-08-07 | 3,800 | $5.80 | $22.0K | 43,693 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2018-01-11 | 2018-01-16 | 42,700 | — | $0 | 42,700 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2017-01-25 | 2017-01-26 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2016-08-16 | 2016-08-17 | 3,000 | $10.53 | $31.6K | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2015-08-05 | 2016-08-17 | 3,000 | $17.92 | $53.8K | 3,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2015-08-04 | 2015-08-06 | 46,616 | — | $0 | 46,616 | SEC↗ |